Fisher Funds Management’s AbbVie ABBV Stock Holding History

Fisher Funds Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1M	Sell	99,740 -5,778	-5%	-$1.24M	0.71%	47
2026 Q1	$22.9M	Sell	105,518 -23,961	-19%	-$5.32M	0.67%	43
2025 Q4	$29.7M	Hold	129,479	–	–	0.77%	40
2025 Q3	$30M	Hold	129,479	–	–	0.79%	41
2025 Q2	$24M	Sell	129,479 -20,753	-14%	-$3.86M	0.57%	43
2025 Q1	$31.5M	Hold	150,232	–	–	0.76%	32
2024 Q4	$26.6M	Buy	+150,232	New	+$27.6M	0.64%	37

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Fisher Funds Management's ABBV Position: Q2 2026 in Review

Fisher Funds Management reduced its AbbVie (ABBV) stake by 5.5% in Q2 2026, selling an estimated $1.24M and leaving 99,740 shares worth $25.1M. The position accounts for 0.71% of the portfolio, ranked #47.

Fisher Funds Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $31.5M in Q1 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fisher Funds Management held 99,740 shares of AbbVie worth $25.1M as of Q2 2026.
Fisher Funds Management sold 5,778 AbbVie shares in Q2 2026, an estimated $1.24M.
AbbVie made up 0.71% of Fisher Funds Management's portfolio in Q2 2026, its #47 holding.
Fisher Funds Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Fisher Funds Management's AbbVie position peaked at $31.5M in Q1 2025.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.